论文部分内容阅读
扎鲁司特(zafirlukast,1),化学名为[3-[[2-甲氧基-4-[(2-甲基苯磺酰胺基)羰基]苯基]甲基]-1-甲基-1H-吲哚-5-基]氨基甲酸环戊酯,由阿斯利康公司于1996年首先在爱尔兰上市,后分
Zafirlukast (1), chemically identified as [3 - [[2-methoxy-4- [(2- methylphenylsulfonamido) carbonyl] phenyl] methyl] Indol-5-yl] carbamate, first marketed in Ireland by AstraZeneca in 1996, after which point